Menu
close
Menu
close
Menu
close
Menu
close
Menu
close
Menu
close

On-Demand Webinars

Watch our webinars to discover how our solutions advance data-driven medicine, improving health outcomes. To view our upcoming live webinars please visit our events page here.
Area of Interest
Alamut(3)
BioPharma(1)
Blood Cancers(6)
Diagnostics(1)
Genomics(4)
Hereditary Cancers(2)
Inherited Disorders(3)
Liquid Biopsy(5)
Platform(7)
Radiomics(1)
Rare Disorders(7)
Solid Tumors(14)

All On-Demand Webinars

10 of 41
 Upcoming Events & Webinars
Event
Insights with Impact: Empowering Laboratories with a Decentralized MSK Solution for CGP

Comprehensive genomic profiling (CGP) using a matched tumor-normal approach can help improve somatic detection rate and streamline interpretation.

Areas of Interest:

Solid Tumors
Event
Advancing Precision Oncology with a Matched Tumor-Normal Approach: Insights From the Clinic

This webinar presents an in-depth look at how Memorial Sloan Kettering Cancer Center (MSK) is routinely using its molecular assays — MSK-IMPACT and MSK-ACCESS — together to inform precision oncology approaches.

Areas of Interest:

Liquid Biopsy, Solid Tumors
Event
Enhancing MRD Detection in AML: Insights From ASST Papa Giovanni XXIII Hospital’s NGS-Based Approach

In this webinar, Silvia Salmoiraghi, biologist at ASST Papa Giovanni XXIII Hospital in Bergamo, Italy, discuss the performance of the SOPHiA DDM™ Residual Acute Myeloid (RAM) Solution.

Areas of Interest:

Blood Cancers
Event
Advancing precision oncology with MSK-ACCESS® powered with SOPHiA DDM™ - ELBS & SOPHiA GENETICS webinar (European Liquid Biopsy Society)

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, recently joined the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care. SOPHiA GENETICS offers a comprehensive […]

Areas of Interest:

Liquid Biopsy
Event
Enhancing variant interpretation: Obtaining answers from a vast universe of data

Pinpointing pathogenic mutations from large, complex datasets can be difficult, time-consuming, and somewhat overwhelming. So, how can you streamline your genomic analysis, to make it quicker, easier, and more efficient? In this webinar you will learn how Alamut™ Visual Plus enables clinical researchers to: ➡️ Resolve splice-site variants using splicing scores and exonic splicing enhancer […]

Areas of Interest:

Alamut, Rare Disorders
Event
Webinar Series - Episode 2: Decoding Complexity: Advanced Techniques for Detecting Low Allele Frequency Variants

Decoding Complexity – Overcoming Real-World Challenges in Variant Analysis Join us for the second episode of our webinar series, where we delve deeper into the complexities of variant analysis. Our esteemed bioinformatics experts will share practical solutions to real-world challenges in this field. Embark on a journey with us as we explore the advanced strategies […]

Areas of Interest:

Liquid Biopsy, Platform
Event
Unlocking precision medicine through high-throughput sequencing in pharmacogenetics: RNPGx experience

Join us for an enlightening webinar on the evolution of pharmacogenetics, from its historical roots to the impact of groundbreaking innovations and the establishment of specialist foundations. We will explore the introduction of crucial guidelines and annotations that have paved the way for the development of key technologies and solutions in this field. Learn how […]

Areas of Interest:

Inherited Disorders
Event
Decoding complexity: Tackling real-world challenges in variant analysis

Welcome to the inaugural episode of our new webinar series - Decoding complexity: Tackling real-world challenges in variant analysis. Prepare to embark on an enlightening journey as we tap into the wealth of knowledge possessed by our esteemed bioinformatics experts, who will be sharing practical solutions to real-world challenges in variant analysis. Each installment of […]

Areas of Interest:

Platform
Event
Addressing pharmacogenetics in routine NGS workflows​​

At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. In this Webinar our partners share how the analytical technology and dedicated features in the SOPHiA DDM™️ Platform have enabled the accurate detection and streamlined assessment of variants associated with Rare Diseases and Pharmacogenomics.​​Discover how the […]

Areas of Interest:

Inherited Disorders
Event
Advancements in Clinical Management of Ovarian Cancer: Integrating HRD and BRCA Status With a Decentralized Solution

The webinar aims to provide a comprehensive overview of the latest advancements in the clinical management of high-grade ovarian cancer, with a focus on incorporating information regarding homologous recombination deficiency (HRD) and BRCA statuses obtained through decentralized, in-house assays. Four experts in the field — one anatomic pathologist, two medical oncologists, and one biologist — will present selected […]

Areas of Interest:

Solid Tumors

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.